Key result
Heart failure hospitalizations present a significant clinical and economic burden, highlighting the need for novel therapeutic and monitoring approaches to improve outcomes and reduce readmissions.
Highlights the clinical and economic burden of heart failure hospitalizations and the need for novel therapeutic and monitoring approaches to improve outcomes and reduce readmissions.
Answers are grounded in this paper and cite their sources.
Urges adoption of strategies to curb HF readmissions; leaves open which novel therapies or monitoring tools will prove effective.
The growing heart failure (HF) epidemic places an enormous clinical and economic burden on the health care system. The clinical and financial burden related to HF hospitalizations has led to great interest in both improving related outcomes and decreasing costs of care. Besides adhering to existing guidelines, newer approaches to managing these patients, both in terms of monitoring and developing novel therapeutic approaches, are needed. Significant opportunities exist to improve the outcomes for patients with HF, especially those who have been hospitalized. These efforts are even more important now that readmission rates for HF have quality and reimbursement implications.
No takes yet. Share an insight, caveat, or question.
Butler et al. (2012) conducted a review in Heart failure. Heart failure hospitalizations present a significant clinical and economic burden, highlighting the need for novel therapeutic and monitoring approaches to improve outcomes and reduce readmissions.
Synapse has enriched 10 related papers. Consider them for comparative context: